Superior Planning, LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

Superior Planning, LLC’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$372	Buy	+23	New	+$367	﹤0.01%	1941

Other funds holding AUPH

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return

Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return

Superior Planning, LLC's AUPH Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 23 shares worth $372. The stake represents ﹤0.01% of the portfolio and ranks #1941 among its holdings.

162 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

Superior Planning, LLC held 23 shares of Aurinia Pharmaceuticals worth $372 as of Q3 2026.
Aurinia Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1941 holding.
162 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.